HAVCR2 and hepatocellular carcinoma: TIGIT and TIM3 are important immune checkpoint molecules, and blocking their signaling pathways can effectively restore the function of T cells and NK cells, enhancing anti-tumor immune responses, making them potential therapeutic targets for HCC (74, 75).